IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $944,996 | -15.9% | 59,546 | 0.0% | 0.45% | -12.7% |
| Q2 2023 | $1,123,634 | +391.4% | 59,546 | 0.0% | 0.52% | +318.5% |
| Q1 2023 | $228,657 | -22.6% | 59,546 | 0.0% | 0.12% | -33.7% |
| Q4 2022 | $295,348 | +1.8% | 59,546 | -2.0% | 0.19% | +3.3% |
| Q3 2022 | $290,000 | +1.8% | 60,787 | -4.2% | 0.18% | +7.7% |
| Q2 2022 | $285,000 | -13.9% | 63,451 | -8.8% | 0.17% | +17.5% |
| Q1 2022 | $331,000 | -35.9% | 69,561 | 0.0% | 0.14% | -27.0% |
| Q4 2021 | $516,000 | – | 69,561 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |